Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01085864 · ClinicalTrials.gov registry record
Biomarkers for Diagnosis of Lung Nodules
A clinical trial of Lung Abscess, sponsored by University of Colorado, Denver.
- Active
- Registry status
- 550
- Enrollment target
- 1
- Study location
NCT01085864 is a study of Lung Abscess that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 550 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01085864, a study of Lung Abscess, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
A need exists for non-invasive testing to aid in clinical decision-making for Computerized Tomography (CT) scan detected lung nodules of indeterminate etiology. The investigators hypothesize that biomarkers detectable in blood, sputum or urine may be useful for guiding clinical decisions in the setting of CT detected lung nodules to determine which nodules are malignant and which are benign. The investigators also hypothesize that these biomarkers will decrease in concentration to the normal range after successful surgical treatment of malignant lung nodules.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2010-03-17 |
| Est. Completion | 2027-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01085864
The ClinicalTrials.gov registry entry for NCT01085864 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Abscess appearing as the primary indexed condition, and to 0 interventions.
NCT01085864 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01085864 about?
NCT01085864 is a clinical study titled "Biomarkers for Diagnosis of Lung Nodules". A need exists for non-invasive testing to aid in clinical decision-making for Computerized Tomography (CT) scan detected lung nodules of indeterminate etiology. The investigators hypothesize that biomarkers detectable in blood, sputum or urine may be useful for guiding clinical decisions in the sett...
What is the current status of trial NCT01085864?
This trial is currently active not recruiting. The enrollment target is 550 participants. The study started on 2010-03-17. Estimated completion is 2027-10-01.
What conditions does trial NCT01085864 study?
This clinical trial studies the following conditions: Lung Abscess.
Who is sponsoring clinical trial NCT01085864?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01085864 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.